The 4th Annual Extractables & Leachables Summit 2024 focuses on the critical assessment phase in biopharmaceutical development—evaluating extractables and leachables. Regulatory bodies emphasize understanding pharmaceutical interactions with container closure systems, drug delivery devices, and bioprocess manufacturing. Our virtual conference unites scientists, toxicologists, and E&L managers to share insights on analytical methods, regulatory updates, risk-based E&L programs, chemical characterization, and toxicological risk assessment. Discussions cover thresholds, medical device materials, ISO 10993-18, and tailored systems for diverse products. Join us to explore cutting-edge approaches in analysis and testing, mitigating E&L risks, and ensuring patient safety and product integrity.

 [Read on www.uventia.com](https://www.uventia.com/event/4th-annual-extractables-leachables-summit-2024/)

Continue reading at uventia.com

Biosimilar Pharmaceuticals Biotech Biochemists and Biophysicists Chemistry, Pharmaceutical Pharma Industry Pharmaceuticals, Biotechnology & Drug Discovery Technologies Chemists and Materials Scientists

Facebook Share

Twitter Share

Linkedin Share

Email Share